F108L (p.Phe108Leu) variant of APOH (Beta-2-glycoprotein 1)
F108L (p.Phe108Leu) in APOH (Beta-2-glycoprotein 1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
F108L (p.Phe108Leu) variant details
- p.Phe108Leu
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available